Form 4 for CSBR CHAMPIONS ONCOLOGY, INC.
Accepted 2024-01-05 00:00:00 ET · period of report 2023-10-17 · accession 0001628280-24-000639 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-05 | 2023-10-17 | CSBR | ACKERMAN JOEL | Dir | M - OptEx | $2.10 | +114.6K | 857.0K | +15% | +$240.6K |
| DM | 2024-01-05 | 2023-10-17 | CSBR | ACKERMAN JOEL | Dir | M - OptEx | $2.10 | -114.6K | 0 | -100% | -$240.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-17 | M | A | 114,552 | $2.10 | 856,997 | D | — | — | |
| 2 | Derivative | Option to purchase Common Stock | 2023-10-17 | M | D | 100,000 | $2.10 | 0 | D | $2.10 · 2016-07-19 to 2023-11-05 | 100,000 Common Stock | (F1) 84,600 options were immediately exercisable upon grant on July 19, 2016 with the remaining options vesting on August 5, 2016 and November 5, 2016. |
| 3 | Derivative | Option to purchase Common Stock | 2023-10-17 | M | D | 14,552 | $2.10 | 0 | D | $2.10 · 2016-07-19 to 2023-11-05 | 14,552 Common Stock | (F2) The options were immediately exercisable upon grant on July 19, 2016. |